Tested Applications
| Positive WB detected in | PC-3 cells, Jurkat cells, HEK-293 cells |
| Positive IP detected in | PC-3 cells |
| Positive IF/ICC detected in | PC-3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13510-1-AP targets eEF2K in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4432 Product name: Recombinant human EEF2K protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 376-725 aa of BC032665 Sequence: LSENSGDENMSDVTFDSLPSSPSSATPHSQKLDHLHWPVFSDLDNMASRDHDHLDNHRESENSGDSGYPSEKRGELDDPEPREHGHSYSNRKYESDEDSLGSSGRVCVEKWNLLNSSRLHLPRASAVALEVQRLNALDLEKKIGKSILGKVHLAMVRYHEGGRFCEKGEEWDQESAVFHLEHAANLGELEAIVGLGLMYSQLPHHILADVSLKETEENKTKGFDYLLKAAEAGDRQSMILVARAFDSGQNLSPDRCQDWLEALHWYNTALEMTDCDEGGEYDGMQDEPRYMMLAREAEMLFTGGYGLEKDPQRSGDLYTQAAEAAMEAMKGRLANQYYQKAEEAWAQMEE Predict reactive species |
| Full Name | eukaryotic elongation factor-2 kinase |
| Calculated Molecular Weight | 725 aa, 100 kDa |
| Observed Molecular Weight | 100 kDa |
| GenBank Accession Number | BC032665 |
| Gene Symbol | EEF2K |
| Gene ID (NCBI) | 29904 |
| RRID | AB_2277761 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O00418 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for eEF2K antibody 13510-1-AP | Download protocol |
| IP protocol for eEF2K antibody 13510-1-AP | Download protocol |
| WB protocol for eEF2K antibody 13510-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The eEF2K antibody (Cat# 13510-1-AP) has 10 total citations published in journals including Cell Metabolism, Cancer Letters, Journal of Medicinal Chemistry, Cells, International Journal of Molecular Sciences, Journal of Molecular Medicine, Medical Oncology, JOR Spine, Journal of Biomedical Research, and Oncology Letters. Research fields span AMPK/mTOR signaling, autophagy, cancer biology (triple-negative breast cancer, radiation sensitivity), drug repurposing, fibrosis, intervertebral disc degeneration, and meiotic spindle organization.
| Species | Application | Title |
|---|---|---|
Cancer Lett eEF-2 Kinase-targeted miR-449b confers radiation sensitivity to cancer cells. | ||
J Med Chem Fluoxetine-Conjugated Platinum(IV) Prodrugs Targeting eEF2K and Conquering Multidrug Resistance against Triple-Negative Breast Cancer | ||
Cells SIRT1 Protects the Heart from ER Stress-Induced Injury by Promoting eEF2K/eEF2-Dependent Autophagy.
| ||
Int J Mol Sci Integrative Transcriptomic Analysis Identifies Shared Immune-Fibrotic Transcriptional Programs Across Crohn's Disease and Idiopathic Pulmonary Fibrosis. | ||
J Mol Med (Berl) FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells. |









